These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 34073805)
81. Characterization of Antibody-Drug Conjugate Pharmacokinetics and in Vivo Biotransformation Using Quantitative Intact LC-HRMS and Surrogate Analyte LC-MRM. Huang Y; Mou S; Wang Y; Mu R; Liang M; Rosenbaum AI Anal Chem; 2021 Apr; 93(15):6135-6144. PubMed ID: 33835773 [TBL] [Abstract][Full Text] [Related]
82. An overview of site-specific methods for achieving antibody drug conjugates with homogenous drug to antibody ratio. Hingorani DV Expert Opin Biol Ther; 2024; 24(1-2):31-36. PubMed ID: 38247196 [TBL] [Abstract][Full Text] [Related]
83. [Bioanalysis in the development of antibody-drug conjugates]. Li XL; Chen XY; Zhong DF Yao Xue Xue Bao; 2016 Apr; 51(4):517-28. PubMed ID: 29859519 [TBL] [Abstract][Full Text] [Related]
84. Development of Solid-Phase Site-Specific Conjugation and Its Application toward Generation of Dual Labeled Antibody and Fab Drug Conjugates. Puthenveetil S; Musto S; Loganzo F; Tumey LN; O'Donnell CJ; Graziani E Bioconjug Chem; 2016 Apr; 27(4):1030-9. PubMed ID: 26942771 [TBL] [Abstract][Full Text] [Related]
86. Site-Specific Conjugation of Monomethyl Auristatin E to Anti-CD30 Antibodies Improves Their Pharmacokinetics and Therapeutic Index in Rodent Models. Lhospice F; Brégeon D; Belmant C; Dennler P; Chiotellis A; Fischer E; Gauthier L; Boëdec A; Rispaud H; Savard-Chambard S; Represa A; Schneider N; Paturel C; Sapet M; Delcambre C; Ingoure S; Viaud N; Bonnafous C; Schibli R; Romagné F Mol Pharm; 2015 Jun; 12(6):1863-71. PubMed ID: 25625323 [TBL] [Abstract][Full Text] [Related]
87. Current ADC Linker Chemistry. Jain N; Smith SW; Ghone S; Tomczuk B Pharm Res; 2015 Nov; 32(11):3526-40. PubMed ID: 25759187 [TBL] [Abstract][Full Text] [Related]
88. Development of an Automated, High-Throughput Methodology for Native Mass Spectrometry and Collision-Induced Unfolding. Juliano BR; Keating JW; Li HW; Anders AG; Xie Z; Ruotolo BT Anal Chem; 2023 Nov; 95(45):16717-16724. PubMed ID: 37924308 [TBL] [Abstract][Full Text] [Related]
89. Drug-to-antibody determination for an antibody-drug-conjugate utilizing cathepsin B digestion coupled with reversed-phase high-pressure liquid chromatography analysis. Adamo M; Sun G; Qiu D; Valente J; Lan W; Song H; Bolgar M; Katiyar A; Krishnamurthy G J Chromatogr A; 2017 Jan; 1481():44-52. PubMed ID: 28017567 [TBL] [Abstract][Full Text] [Related]
90. The impact of trisulfide modification of antibodies on the properties of antibody-drug conjugates manufactured using thiol chemistry. Liu R; Chen X; Dushime J; Bogalhas M; Lazar AC; Ryll T; Wang L MAbs; 2017 Apr; 9(3):490-497. PubMed ID: 28136017 [TBL] [Abstract][Full Text] [Related]